柴苓杉貝湯聯(lián)合RCHOP方案治療氣郁痰結(jié)型NHL的臨床療效觀察
[Abstract]:Objective: to evaluate the clinical efficacy and safety of Chailing Shanbei decoction combined with RCHOP regimen in the treatment of NHL (non-Hodgkin's lymphoma) with qi depression and phlegm. Methods: 72 patients were randomly divided into two groups: group A (n = 36) and group B (n = 36), who were treated with Chinese medicine plus chemotherapy (group A) and chemotherapy group (group B, n = 36). Two cycles of RCHOP chemotherapy were given to both groups, in which group A took Chailing Shanbei decoction orally at the beginning of RCHOP regimen, 150m1/ twice a day (sooner or later). The changes of myelosuppression, peripheral blood (WBC, NEUT, PLT, Hb), clinical symptoms and quality of life of traditional Chinese medicine, liver and kidney function and abnormal ECG were observed after treatment. Results: 1 Evaluation of curative effect: the incidence of myelosuppression was 68.57% in group A and 94.29% in group B, which was significantly lower in group A than in group B (P0.05:). A group and B group). The difference was statistically significant (P0.05). Compared with group B, the hemogram of group A decreased slightly after treatment, the difference was statistically significant (P0.05). The effective rate of TCM symptom improvement in group A was 65.71%, group B was 8.57%, group A was higher than group B, the difference was statistically significant (P0.05). A group and B group, the difference was statistically significant (P0.05). Compared with group B, the total score of TCM symptom and the score of single symptom decreased significantly in group A after treatment, the difference was statistically significant (P0.05). Compared with group B, the scores of KPS in group A increased significantly after treatment (P0.05). (2) Evaluation of abnormal liver and kidney function and ECG: normal renal function; Liver function abnormality situation contrast (P0.05), the difference is not statistically significant, the ECG abnormal situation contrast (P0.05), the difference is not statistically significant. Conclusion: 1. Chailing Shanbei decoction can reduce the incidence of chemotherapy myelosuppression and improve the degree of myelosuppression. 2. Chailing shanbei decoction can improve the decrease of hemogram. 3. Chailing Shanbei decoction can improve the clinical symptoms of traditional Chinese medicine and improve the quality of life of patients.
【學(xué)位授予單位】:黑龍江中醫(yī)藥大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2016
【分類號】:R733.1
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 蔡青山;柴胡青陳湯加減治療氣郁咳嗽48例[J];河北中醫(yī);2005年08期
2 馬汴梁;;淺論氣郁[J];山東中醫(yī)雜志;1986年02期
3 王建剛;;淺論氣郁[J];陜西中醫(yī)函授;1989年04期
4 陳霞波;蘇瓊;;血虛氣郁體質(zhì)從肝論[J];中國民族民間醫(yī)藥;2010年24期
5 劉美之;倪誠;;中醫(yī)氣郁體質(zhì)與方藥干預(yù)研究述評[J];山西中醫(yī)學(xué)院學(xué)報;2012年03期
6 王鵬;;氣郁體質(zhì)的研究進(jìn)展[J];中國保健營養(yǎng);2013年06期
7 ;妊娠氣郁案[J];浙江中醫(yī)雜志;2001年12期
8 馮娜;賀娟;王琦;;氣郁體質(zhì)相關(guān)差異基因研究[J];中國中西醫(yī)結(jié)合雜志;2011年01期
9 ;氣郁體質(zhì)怎樣養(yǎng)生[J];科技視界;2011年13期
10 劉存光;;氣郁體質(zhì)的養(yǎng)生:演藝明星多氣郁(上)[J];卓越理財;2013年10期
相關(guān)會議論文 前2條
1 王芙蓉;周鳳珍;宋蕾;;氣郁體質(zhì)之食藥養(yǎng)生[A];中華中醫(yī)藥學(xué)會第八屆中醫(yī)體質(zhì)研討會暨中醫(yī)健康狀態(tài)認(rèn)知與體質(zhì)辨識研究論壇論文集[C];2010年
2 蘇榮立;范宇;;淺談治氣郁失眠癥之體會[A];中華中醫(yī)藥學(xué)會中醫(yī)、中西醫(yī)結(jié)合治療常見病研討會論文集[C];2007年
相關(guān)重要報紙文章 前3條
1 河北省滄州中西醫(yī)結(jié)合醫(yī)院治未病中心 侯獻(xiàn)兵;氣郁體質(zhì)調(diào)養(yǎng)有招[N];中國中醫(yī)藥報;2013年
2 衣曉峰 張銳;調(diào)查顯示:哈爾濱八成市民體質(zhì)“氣郁”兼“痰濕”[N];中國醫(yī)藥報;2014年
3 南京中醫(yī)藥大學(xué)周仲瑛名醫(yī)工作室 郭立中 朱W,
本文編號:2455439
本文鏈接:http://www.sikaile.net/yixuelunwen/zlx/2455439.html